 |
|
Scientific Report 2007
Immunology
Control
of V(D)J Recombination and Formation of the Antibody Repertoire in Normal and Autoimmune
Mice
A.J.
Feeney, C.R. Espinoza, J. Lamoureux, M. Cherrier, C.R. Xu, J. Carey, S. Salerno, T. Wong
A
main focus of our laboratory is the molecular analysis of factors that influence
the composition of the antibody repertoire and elucidation of the mechanisms that
control the V(D)J rearrangement process. In each precursor B lymphocyte, a different
set of V, D, and J genes recombine to form exons for the light and heavy chains
of the antibody molecule. Each locus has many V, D, and J genes, but the gene segments
are not used equally. One of our goals is to understand the basis of this nonrandom
use of gene segments.
We previously
showed that much of this bias occurs because V genes undergo recombination with
different intrinsic frequencies due to differences in the sequence of the binding
site for the recombinase flanking each gene segment. However, other factors clearly
influence recombination frequencies; currently, we are focusing on the role of transcription
factors and chromatin modifications in controlling accessibility to V(D)J recombination
and recombination frequency.
Genes in loci
that are undergoing V(D)J recombination are often associated with histones that
are acetylated. We hypothesized that the extent of histone modification affects
the frequency of recombination of individual genes, and indeed we observed a positive
correlation between the relative rearrangement frequency of individual genes in
vivo and the extent of acetylation of histones associated with those genes, as assessed
by chromatin immunoprecipitation. We are now identifying other histone modifications
that likely play a role in regulating gene use in the antibody repertoire.
We have also
uncovered a novel role for the transcription factor Pax5 in promoting V(D)J rearrangement.
Pax5 is essential for B-cell development. In the absence of Pax5, VH-to-DJH
rearrangement is severely impaired. We found Pax5 binding sites in the coding regions
of many VH genes. Furthermore, in collaboration with Z. Zhang and
M. Cooper, University of Alabama, Birmingham, we showed that Pax5 binds to the recombinase
proteins RAG1 and RAG2. Hence, we propose that Pax5 may recruit RAG1 or RAG2 to
the recombination signal sequence or may stabilize the interaction of the RAG complex
with its binding site. We are investigating other roles of Pax5 in shaping the antibody
repertoire.
B cells in
the spleen are divided into functionally distinct subsets. We are investigating
differences in the antibody repertoires between B cells in the marginal zone, which
respond to blood-borne pathogens, and B cells in the follicle, the largest population
of splenic B cells. We previously showed that B cells made during fetal and neonatal
life lack an enzyme, terminal deoxynucleotidyl transferase; this enzyme greatly
diversifies the antibody repertoire in adults. We now have evidence that B cells
generated early in ontogeny are preferentially selected into the marginal zone compartment,
suggesting that the fetal/neonatal repertoire of antibodies, which is quite different
from that generated in adults, may be particularly useful against blood-borne pathogens.
In other studies,
we are examining the breakdown of B-cell tolerance in autoimmunity. When precursor
B cells successfully recombine both heavy- and light-chain gene segments, they
express a B-cell receptor for the first time. If the receptor is autoreactive, then
the immature B cell normally continues to undergo light-chain V-J rearrangement
until an innocuous receptor is made. This process is termed receptor editing
and is an important checkpoint in B-cell tolerance. We have evidence that this process
is not functioning as efficiently in lupus-prone mice as in nonautoimmune mice,
and we are investigating why this difference occurs. Such misregulation of this
key checkpoint could lead to the release of autoreactive B cells into the periphery,
where they can become activated to secrete autoantibodies and cause autoimmune disease.
Publications
Espinoza,
C.R., Feeney, A.J. Chromatin
accessibility and epigenetic modifications differ between frequently and infrequently
rearranging VH genes. Mol. Immunol. 44:2675, 2007.
Feeney,
A.J. Genetic and epigenetic
control of V gene rearrangement frequency. In: V(D)J Recombination. Ferrier,
P. (Ed.). Landes Bioscience, Austin, TX, in press.
Lamoureux,
J.L., Watson, L.C., Cherrier, M., Skog, P., Nemazee, D., Feeney, A.J. Reduced
receptor editing in lupus-prone MRL/lpr mice. J. Exp. Med., in press.
|
 |